Mucinex doubles retailer demand forecast accuracy with Kinsa's illness solution
The Challenge
COVID-19 made seasonal illness timing unpredictable. Symptom-relieving medications like Mucinex saw volatile sales, making it critical to reduce out-of-stocks by improving demand forecasting for a top 3 national retailer.
The Solution
Kinsa deployed its Illness Based Sales Demand Solution, leveraging a proprietary 12-week cough, cold and flu forecast to accurately predict Mucinex product demand, reducing the retailer's forecasting error by 48%.
"Our partnership with Kinsa helps us understand where, when and how much demand there will be for our products, allowing us to better collaborate with our retail partners."
Key Highlights
- Proprietary 12-week illness forecast
- Reduced Mucinex out-of-stocks at shelf
- Outperformed retailer's traditional data set
- Optimized supply chain during unprecedented season

48%
Reduction in forecasting error
$2M+
Additional product demand identified
